Vaccsys Inc. Receives $9,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Vaccsys Inc.
  • Mailing Address
    1124 Columbia St Seattle, WA 98104
  • Company Description
    The company is developing vaccines that “regulate immune responses by targeting dendritic cell biology with combinations of proprietary vectors and adjuvants.”
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Alta Partners
  • Venture Investor
    The Column Group
  • Venture Investor
    Versant Ventures

Trending on Xconomy